Advanced company searchLink opens in new window

AMRYT PHARMA (UK) LIMITED

Company number 10463152

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
15 Nov 2024 CS01 Confirmation statement made on 3 November 2024 with no updates
05 Sep 2024 AA Full accounts made up to 31 December 2023
15 Jan 2024 TM01 Termination of appointment of Thomas Joseph Delahoyde as a director on 1 January 2024
16 Nov 2023 CS01 Confirmation statement made on 3 November 2023 with no updates
23 Sep 2023 AA Full accounts made up to 31 December 2022
08 Aug 2023 PSC05 Change of details for Amryt Pharma Plc as a person with significant control on 4 August 2023
08 Aug 2023 TM02 Termination of appointment of Corporation Service Company (Uk) Limited as a secretary on 1 August 2023
26 Jul 2023 TM01 Termination of appointment of Rory Peter Nealon as a director on 13 July 2023
26 Jul 2023 TM02 Termination of appointment of Rory Peter Nealon as a secretary on 13 July 2023
01 Jun 2023 AP01 Appointment of Mr Thomas Joseph Delahoyde as a director on 26 May 2023
01 Jun 2023 AP03 Appointment of Mr Matthew Hammond Wiggetts as a secretary on 26 May 2023
01 Jun 2023 AP01 Appointment of Mr Alessio Bastianello as a director on 26 May 2023
01 Jun 2023 TM01 Termination of appointment of Joseph Wiley as a director on 26 May 2023
01 Jun 2023 AP01 Appointment of Mr Matthew Hammond Wiggetts as a director on 26 May 2023
17 Nov 2022 CS01 Confirmation statement made on 3 November 2022 with no updates
08 Nov 2022 AA Full accounts made up to 31 December 2021
02 Mar 2022 MR04 Satisfaction of charge 104631520001 in full
06 Jan 2022 AA Full accounts made up to 31 December 2020
01 Dec 2021 DISS40 Compulsory strike-off action has been discontinued
30 Nov 2021 CH01 Director's details changed for Joseph Wiley on 26 November 2021
30 Nov 2021 CH01 Director's details changed for Mr Rory Peter Nealon on 26 November 2021
30 Nov 2021 CH03 Secretary's details changed for Rory Peter Nealon on 26 November 2021
30 Nov 2021 CS01 Confirmation statement made on 3 November 2021 with no updates
30 Nov 2021 PSC02 Notification of Amryt Pharma Plc as a person with significant control on 23 September 2019
30 Nov 2021 PSC07 Cessation of Amryt Pharma Holdings Limited as a person with significant control on 23 September 2019